The human evidence is still catching up, and that's the part the internet conveniently skips
An FDA peptide review is scheduled for July 2324, 2026, and it could shape how some of the most-studied peptides in regenerative and longevity medicine are accessed going forward
Chronic in vivo Ipamorelin treatment stimulates body weight gain and growth hormone (GH) release in vitro in young female rats U.S
1) Targets Fat Metabolism (AOD 9604) Supports pathways commonly associated with: fat breakdown stubborn fat reduction support lean tissue protection during dieting 2) Supports Energy + Metabolic Flexibility (MOTS-c) Supports: mitochondrial energy production better fuel utilization (carbs + fats) metabolic resilience during stress, dieting, or busy seasons 3) Supports Visceral Fat + Midsection Goals (Tesamorelin) Supports: visceral fat reduction in certain individuals midsection-focused body composition goals metabolic pathway support under provider guidance 4) Supports Recovery + Sleep (Ipamorelin) Supports: deeper, more restorative sleep better recovery between workouts improved consistency (because you feel better while leaning out) In simple terms: AOD + MOTS-c help the metabolism feel on, Tesamorelin supports midsection/visceral fat goals, and Ipamorelin helps you recover and sleep so you can stay consistent
Designed to help maintain skin structure, support antioxidant defenses, and promote healthy skin function over time
